ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 90 filers reported holding ONCOCYTE CORP in Q1 2021. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $15 | -99.8% | 65,123 | +516.8% | 0.00% | 0.0% |
| Q3 2022 | $8,000 | -57.9% | 10,558 | -49.1% | 0.00% | -50.0% |
| Q2 2022 | $19,000 | -78.7% | 20,741 | -44.0% | 0.00% | -80.0% |
| Q4 2020 | $89,000 | +74.5% | 37,030 | +39.7% | 0.01% | +66.7% |
| Q2 2020 | $51,000 | 0.0% | 26,504 | +16.2% | 0.01% | +20.0% |
| Q4 2019 | $51,000 | -55.3% | 22,801 | -21.1% | 0.01% | -16.7% |
| Q1 2019 | $114,000 | – | 28,883 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 14,716,204 | $20,456,000 | 1.61% |
| PURA VIDA INVESTMENTS, LLC | 6,022,534 | $8,371,000 | 0.43% |
| P.A.W. CAPITAL CORP | 199,700 | $278,000 | 0.30% |
| Penbrook Management LLC | 229,425 | $319,000 | 0.28% |
| PERKINS CAPITAL MANAGEMENT INC | 39,725 | $55,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 201,047 | $279,000 | 0.05% |
| Private Wealth Partners, LLC | 150,000 | $209,000 | 0.02% |
| Phoenix Holdings Ltd. | 317,138 | $426,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 255,300 | $355,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 157,933 | $226,000 | 0.01% |